#Inflammatory bowel disease treatment

[hospital-26]

Inflammatory bowel disease treatment

Kalyani Hospital, located in Gurgaon, Haryana, offers comprehensive treatment options for individuals suffering from Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis. Their multidisciplinary team of experienced gastroenterologists collaborates to provide personalized care aimed at reducing inflammation, managing symptoms, and enhancing patients' overall gastrointestinal health.

Understanding Inflammatory Bowel Disease (IBD):

IBD encompasses chronic inflammatory conditions of the gastrointestinal tract, primarily Crohn's disease and ulcerative colitis. Symptoms often include abdominal pain, diarrhea, rectal bleeding, fatigue, and weight loss. Effective management is crucial to improve quality of life and prevent complications.

Treatment Approaches at Kalyani Hospital:

Kalyani Hospital employs a range of treatment strategies tailored to the severity and specific needs of each patient:

Medication Therapy: Utilizing anti-inflammatory drugs, immunosuppressants, and biologic therapies to control inflammation and modulate the immune response.

Dietary Modifications: Implementing personalized nutrition plans to alleviate symptoms and promote digestive health.

Lifestyle Changes: Encouraging stress management techniques and regular exercise to support overall well-being.

Surgical Interventions: In cases where medical management is insufficient, surgical options are considered to remove damaged portions of the gastrointestinal tract.

The hospital emphasizes patient education and support throughout the treatment process, ensuring individuals are well-informed and actively involved in their care.

Expert Care Team:

Kalyani Hospital's gastroenterology department is staffed by skilled professionals dedicated to providing high-quality care. Their expertise ensures that patients receive the most effective and up-to-date treatments available.

Contact Information:

For more details or to schedule a consultation, you can reach Kalyani Hospital at:

Phone: +91-124-4666999

Email: managingkalyani@gmail.com

Address: Opp. Govt Girls College, Anamika Enclave, MG Road, Near Sec-14, Gurgaon, Haryana – 122001

For additional information, visit their official website:

Kalyani Hospital

If you or a loved one is dealing with IBD, Kalyani Hospital's comprehensive and compassionate approach may provide the relief and support needed to manage this condition effectively.

[wellesley56]

Joint Wellness Journey with Ultimate Glucosamine

Experience the power of Ultimate Glucosamine for comprehensive joint care. Say farewell to discomfort and rediscover the joy of pain-free movement.

Discover the Best Gut Health Supplements for Effective Inflammatory Bowel Disease Treatment

Explore top-rated supplements to restore gut health and enhance overall well-being. Our curated selection includes the best supplements for gut health, providing effective support for inflammatory bowel disease treatment. Unlock the key to a healthy gut with our trusted and proven dietary supplements.

[harmeet-saggi]

What Is Inflammatory Bowel Disease?

Welcome to a comprehensive exploration of Inflammatory Bowel Disease (IBD), a condition that significantly impacts the lives of many. In our fast-paced world, health concerns are becoming increasingly prevalent, making it crucial to delve into the intricacies of conditions like IBD. From the intricacies of its causes and symptoms to the methods of diagnosis and various treatment options, this journey aims to equip you with the knowledge needed to navigate the complexities of IBD.

[drkiranpeddi]

Inflammatory Bowel Disease and its Treatment in Hyderabad - Dr. Kiran Peddi

Inflammatory Bowel Disease (IBD) is a serious condition that affects the digestive system, causing inflammation and damage to the intestinal walls. It is a chronic condition that can cause severe discomfort, pain, and diarrhea. IBD includes two types of diseases, Crohn's disease, and Ulcerative Colitis. While there is no known cure for IBD, the condition can be managed through proper treatment and medication. In Hyderabad, there are several experienced gastroenterologists and IBD specialists who offer advanced treatment options for patients suffering from this condition.

Finding the Right IBD Specialist in Hyderabad - Dr. Kiran Peddi

If you are experiencing symptoms of IBD, it is important to seek medical attention as soon as possible. In Hyderabad, Dr. Kiran Peddi is an experienced Gastroenterologist and IBD specialist who offer advanced treatment options for patients with IBD. When choosing a specialist, it is important to consider factors such as their experience, reputation, and the services they offer

What is Inflammatory Bowel Disease (IBD)?

Inflammatory Bowel Disease (IBD) is a group of disorders that cause inflammation in the digestive tract. The inflammation can affect different parts of the digestive system, including the small intestine, large intestine, and rectum. The exact cause of IBD is unknown, but researchers believe that a combination of genetic and environmental factors play a role in the development of the condition. IBD is a chronic condition, meaning it persists for a long time and may require ongoing medical treatment to manage symptoms.

Symptoms of Inflammatory Bowel Disease (IBD)

The symptoms of IBD vary from person to person and can range from mild to severe. Common symptoms of IBD include:

Abdominal pain and cramping

Diarrhea

Blood in stool

Weight loss

Fatigue

Loss of appetite

It is important to seek medical attention if you are experiencing any of these symptoms, as early diagnosis and treatment can help prevent the progression of the condition and reduce the risk of complications.

Diagnosis of Inflammatory Bowel Disease (IBD)

Diagnosing IBD involves a thorough evaluation of a patient's medical history, physical examination, and a series of tests, including:

Stool sample analysis

Blood tests

Imaging tests, such as X-rays, CT scans, and MRI

Endoscopic procedures, such as colonoscopy and upper endoscopy

Based on the results of these tests, a gastroenterologist can diagnose IBD and determine the appropriate treatment plan.

Treatment of Inflammatory Bowel Disease (IBD) in Hyderabad

There is no cure for IBD, but the condition can be managed through a combination of medication, lifestyle changes, and other treatments. In Hyderabad, experienced gastroenterologists and IBD specialists offer several advanced treatment options for patients with IBD, including:

Medications: There are several types of medications that can be used to manage IBD, including anti-inflammatory drugs, immunosuppressive drugs, and biologic agents.

Dietary Changes: Patients with IBD may need to make changes to their diet, including avoiding certain foods that can worsen symptoms and increasing their intake of fiber and other nutrients.

Surgery: In severe cases, surgery may be necessary to remove damaged sections of the intestine or to treat other complications of IBD.

It is important to work closely with a gastroenterologist and IBD specialist to determine the best treatment plan for your individual needs and to manage the symptoms of IBD effectively.

Contact info:

+91 9390150150 / 9581000505

Yashoda Hospitals - Somajiguda, Raj Bhavan Rd, Matha Nagar, Somajiguda, Hyderabad, Telangana 500082

Gastro Care Clinics, Unit 201, Surya Arcade, behind Labonel Fine Baking, Cyber Hills Colony, P Janardhan Reddy Nagar, Gachibowli, Hyderabad, Telangana 500032

[hussyknee]

Somehow always manage to forget how painful a flare is until one hits. And then it's like. yeah. An inflamed and swollen large bowel with ruptured ulcers is agonizing.

[drjigarpatel]

Top Laparoscopic Gastro Surgeon in Ahmedabad

Expert laparoscopic gastro surgeon in Ahmedabad, offering advanced treatment for liver diseases, IBD, and digestive health. Specialized in minimally invasive surgeries with endoscopy and colonoscopy for precise care.

[abhilashnale]

Inflammatory Bowel Disease Treatment Market Global Demand Analysis: Sales Consumption, Business Scenario, and Expert Reviews, Forecast by 2032

The Market Dynamics of the Inflammatory Bowel Disease Treatment

The global Inflammatory Bowel Disease Treatment market has emerged as a critical focal point for businesses, offering a wealth of opportunities and challenges. As industries navigate this complex landscape, understanding the underlying market dynamics becomes crucial for strategic decision-making and growth.

According to Straits Research, the global inflammatory bowel disease treatment market size was valued at USD 20.33 Billion in 2022. It is projected to reach from USD XX Billion in 2023 to USD 27.95 Billion by 2031, growing at a CAGR of 3.6% during the forecast period (2023–2031).

Historically, the Inflammatory Bowel Disease Treatment market has witnessed significant transformations, driven by technological innovations, regulatory changes, and evolving consumer preferences. These shifts have reshaped the market landscape, presenting businesses with new avenues for growth, innovation, and competitiveness.

Note: Our reports are currently under revision. To access the most recent primary and secondary data spanning 2023-2031, inclusive of Cost Module, Business Strategy, and Competitive Landscape insights, please click on ""request free sample report."" Expect the report in your inbox within 24 to 48 hours.

Get Access to a Free Copy of Our Latest Sample Report@https://straitsresearch.com/report/inflammatory-bowel-disease-treatment-market/request-sample

Companies and Manufacturers Covered:

Key market players play a pivotal role in shaping the market narrative. By profiling industry leaders, their strategic initiatives, and competitive positioning, the report offers insights into market dynamics, influencing factors, and growth opportunities. These insights are invaluable for businesses seeking to gain a competitive edge, drive innovation, and capitalize on emerging trends.

AbbVie Inc.

Takeda Pharmaceutical Company Limited

Pfizer Inc

Biogen

Novartis AG, Lilly

UCB S.A.

CELLTRION INC.

Merck & Co., Inc

Johnson & Johnson Services, Inc.

The quantitative analysis accompanying the report offers a decade-long perspective on the market's trajectory. By examining historical data, identifying trends, and forecasting future developments, stakeholders can gain a deeper understanding of market dynamics and make informed decisions.

Buy this Premium Research Report@https://straitsresearch.com/buy-now/inflammatory-bowel-disease-treatment-market

A recent comprehensive analysis provides a detailed overview of the Global Inflammatory Bowel Disease Treatment Market, highlighting key growth drivers, emerging trends, and market dynamics. This report serves as an invaluable resource for businesses, offering insights into the market landscape, competitive positioning, and growth prospects.

Global Regional Outlook:

North America: North America is currently the largest market for Inflammatory Bowel Disease Treatment, accounting for a significant share of the global market.

Asia-Pacific: While the North America leads in market size, Asia-Pacific is emerging as the fastest growing region in the Inflammatory Bowel Disease Treatment market.

Research Methodology

The research methodology employed in curating this report is rigorous and comprehensive. By leveraging both primary and secondary data sources, the report ensures accuracy, reliability, and depth. Through interviews with industry experts, analysis of Inflammatory Bowel Disease Treatment market trends, and examination of key growth drivers, the report offers a holistic view of the market landscape.

Market Segmentation:

By Type

Crohn’s Disease

Ulcerative Colitis

By Drug Class

Aminosalicylates

Corticosteroids

TNF inhibitors

IL inhibitors

Anti-integrin

JAK inhibitors

Others

By Route of Administration

Injectable

Oral

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Ask Here For More Customization Study@https://straitsresearch.com/report/inflammatory-bowel-disease-treatment-market/toc

Report Features:

Actionable market intelligence for strategic decision-making

Comprehensive forecasts spanning 2018to 2031

In-depth growth trend assessments

Segment-specific and regional revenue projections

Competitive analysis and market share insights

Innovative product listings for competitive advantage

Insights into the market implications of COVID-19

Report availability in various formats: PDF, XLS, PPT, and digital dashboards

In conclusion, the global Inflammatory Bowel Disease Treatment market presents a dynamic and evolving landscape for businesses. By understanding market dynamics, leveraging strategic insights, and adopting a proactive approach, businesses can navigate this complex landscape successfully, drive growth, and achieve sustainable success.

Report Customization:

Our report is adaptable to your specific needs. For tailored insights, please reach out to our sales team at sales@straitsresearch.com. Additionally, you can contact our representatives directly at +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.) to discuss your research criteria.

[chetanagp]

Inflammatory Bowel Disease Treatment Market size is expected to grow at a CAGR of 7.9% during the forecast period and the market size is expected to reach nearly US$ 34.67 Bn. by 2029.

[hospital-26]

Inflammatory Bowel Disease Treatment

Inflammatory Bowel Disease (IBD) Treatment at Kalyani Hospital

Inflammatory Bowel Disease (IBD) is a group of chronic conditions, primarily Crohn’s disease and ulcerative colitis, that cause inflammation of the gastrointestinal tract. Managing IBD requires a comprehensive approach involving medical expertise, lifestyle adjustments, and, in some cases, surgical intervention. At Kalyani Hospital, we offer state-of-the-art treatment tailored to the needs of each patient.

Understanding IBD

IBD can significantly impact a patient’s quality of life. Symptoms such as abdominal pain, diarrhea, weight loss, and fatigue are common. Left untreated, IBD may lead to complications like intestinal strictures, fistulas, and an increased risk of colorectal cancer.

Our Approach to IBD Treatment

Kalyani Hospital combines cutting-edge technology with compassionate care to manage and treat IBD effectively. Our multidisciplinary team includes gastroenterologists, dietitians, surgeons, and mental health professionals who work collaboratively to provide holistic care.

Diagnostic Services

Endoscopy and Colonoscopy: Visualize and assess inflammation or damage in the gastrointestinal tract.

Imaging Studies: Advanced imaging such as MRI and CT scans for detailed evaluation.

Laboratory Tests: Comprehensive blood and stool tests to identify markers of inflammation and infection.

Medical Treatment

Medication Management:

Anti-inflammatory drugs (e.g., aminosalicylates and corticosteroids).

Immunosuppressive agents to reduce immune system overactivity.

Biologic therapies targeting specific inflammatory pathways.

Nutritional Support:

Tailored diets to reduce symptoms and improve nutrient absorption.

Nutritional supplements, when necessary.

Surgical Options

For patients who do not respond to medication or develop complications, surgical intervention may be required. Common procedures include:

Strictureplasty: Widening narrowed areas of the intestine.

Resection: Removing diseased portions of the intestine.

Colectomy: Removal of the colon, often with ileostomy or ileoanal pouch creation.

Patient-Centric Care

At Kalyani Hospital, we prioritize patient education and support. We provide resources to help patients understand their condition, manage symptoms, and live fulfilling lives. Our team conducts regular follow-ups to monitor progress and adjust treatment plans as needed.

Why Choose Kalyani Hospital?

Expert Team: Highly qualified and experienced specialists in IBD management.

Advanced Facilities: Modern diagnostic and therapeutic technologies.

Comprehensive Care: Integrated services including nutrition, counseling, and rehabilitation.

Personalized Plans: Tailored treatment approaches for each patient’s unique needs.

Contact Us

If you or a loved one is dealing with IBD, Kalyani Hospital is here to help. Contact us at [phone number] or visit our website at [website link] to schedule an appointment. Together, we can manage IBD effectively and improve your quality of life.

[delveinsight12]

Inflammatory Bowel Disease Market expected to rise | Companies- Eli Lilly and Company, Gilead, Galapagos, Protagonist Therapeutics, Athos Therapeutics, expected to drive market

The Inflammatory Bowel Disease market growth is driven by factors like increase in the prevalence of Inflammatory Bowel Disease, investments in research and development, entry of emerging therapies during the study period 2019-2032.

The Inflammatory Bowel Disease market report also offers comprehensive insights into the Inflammatory Bowel Disease market size, share, Inflammatory Bowel Disease epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Inflammatory Bowel Disease market size growth forward. 

Some of the key highlights from the Inflammatory Bowel Disease Market Insights Report:

Several key pharmaceutical companies, including Eli Lilly and Company, Gilead, Galapagos, Protagonist Therapeutics, Athos Therapeutics, and others, are developing novel products to improve the Inflammatory Bowel Disease treatment outlook. 

The total Inflammatory Bowel Disease market size will include the market size of the potential upcoming therapies and current treatment regimens in the seven major markets.

As per DelveInsight analysis, the Inflammatory Bowel Disease market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Inflammatory Bowel Disease Market Landscape

Inflammatory Bowel Disease Overview 

Inflammatory bowel disease (IBD) is a term that describes disorders involving long-standing (chronic) inflammation of tissues in your digestive tract. Types of IBD include: Ulcerative colitis. This condition involves inflammation and sores (ulcers) along the lining of your large intestine (colon) and rectum.

Inflammatory bowel disease (IBD) is a term that describes disorders involving long-standing (chronic) inflammation of tissues in your digestive tract. Types of IBD include:

Ulcerative colitis. This condition involves inflammation and sores (ulcers) along the lining of your large intestine (colon) and rectum.

Crohn's disease. This type of IBD is characterized by inflammation of the lining of your digestive tract, which often can involve the deeper layers of the digestive tract. Crohn's disease most commonly affects the small intestine. However, it can also affect the large intestine and uncommonly, the upper gastrointestinal tract.

Both ulcerative colitis and Crohn's disease usually are characterized by diarrhea, rectal bleeding, abdominal pain, fatigue and weight loss.

For some people, IBD is only a mild illness. For others, it's a debilitating condition that can lead to life-threatening complications.

Inflammatory Bowel Disease Symptoms

Inflammatory bowel disease symptoms vary, depending on the severity of inflammation and where it occurs. Symptoms may range from mild to severe. You are likely to have periods of active illness followed by periods of remission.

Signs and symptoms that are common to both Crohn's disease and ulcerative colitis include:

Diarrhea

Fatigue

Abdominal pain and cramping

Blood in your stool

Reduced appetite

Unintended weight loss

Do you know the treatment paradigms for different countries? Download our Inflammatory Bowel Disease Market Sample Report

Recent breakthrough in the Inflammatory Bowel Disease

FDA approves first oral treatment for moderately to severely active Crohn’s disease: 

FDA has approved Rinvoq (upadacitinib) for adults with moderately to severely active Crohn’s disease who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers. Rinvoq is the first approved oral product available to treat moderately to severely active Crohn’s disease.

Patients should start with 45 mg of Rinvoq once daily for 12 weeks. Following the 12-week period, the recommended maintenance dosage is 15 mg once a day. A maintenance dosage of 30 mg once daily can be considered for patients with refractory, severe, or extensive Crohn’s disease.

Inflammatory Bowel Disease Epidemiology Segmentation 

DelveInsight’s Inflammatory Bowel Disease market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Inflammatory Bowel Disease historical patient pools and forecasted Inflammatory Bowel Disease patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Inflammatory Bowel Disease Market report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into:

Inflammatory Bowel Disease Prevalence 

Age-Specific Inflammatory Bowel Disease Prevalence 

Gender-Specific Inflammatory Bowel Disease Prevalence 

Diagnosed and Treatable Cases of Inflammatory Bowel Disease

Visit for more @ Inflammatory Bowel Disease Epidemiological Insights

Inflammatory Bowel Disease Treatment Market 

The Inflammatory Bowel Disease market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Inflammatory Bowel Disease market trends by analyzing the impact of current Inflammatory Bowel Disease therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

The most common medications used to treat IBD are antibiotics such as metronidazole and ciprofloxacin; ASA anti-inflammatory drugs such as Asacol, Azulfidine, Colazol, Pentasa, Rowasa and Lialda; steroids, such as prednisone, prednisolone or budesonide, immunomodulators such as Imuran(azathioprine), Purinethol, and methotrexate; biologics, such as REMICADE, HUMIRA, CIMZIA, ENTYVIO, STELARA and XELJANZ, nutritional therapy can be used to induce and maintain remission in Crohn’s disease.

There are various drugs currently being studied for the treatment of IBD. The Key players are Eli Lilly and Company, Gilead, Galapagos, Protagonist Therapeutics, Athos Therapeutics, and others.

According to DelveInsight, the Inflammatory Bowel Disease market in 7MM is expected to witness a major change in the study period 2019-2032.

Inflammatory Bowel Disease Key Companies

Eli Lilly and Company

Gilead

Galapagos

Protagonist Therapeutics

Athos Therapeutics

For more information, visit Inflammatory Bowel Disease Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Inflammatory Bowel Disease Market Report:

10 Years Forecast

7MM Coverage 

Descriptive overview of Inflammatory Bowel Disease, causes, signs and symptoms, diagnosis, treatment

Comprehensive insight into Inflammatory Bowel Disease epidemiology in the 7MM

Inflammatory Bowel Disease marketed and emerging therapies 

Inflammatory Bowel Disease companies

Inflammatory Bowel Disease market drivers and barriers 

Key Questions Answered in the Inflammatory Bowel Disease Market Report 2032:

What was the Inflammatory Bowel Disease market share distribution in 2019, and how would it appear in 2032?

What is the total Inflammatory Bowel Disease market size and the market size by therapy across the 7MM for the study period (2019-32)?

What are the important findings from 7MM, and which country will have the greatest Inflammatory Bowel Disease market size from 2019-32?

During the study period (2019-2032), at what CAGR is the Inflammatory Bowel Disease market projected to expand at 7MM?

Table of Contents:

1 Inflammatory Bowel Disease Market Key Comprehensive Insights 

2 Inflammatory Bowel Disease Market Report Introduction

3 Competitive Intelligence Analysis for Inflammatory Bowel Disease

4 Inflammatory Bowel Disease Market Analysis Overview at a Glance

5 Executive Summary of Inflammatory Bowel Disease

6 Inflammatory Bowel Disease Epidemiology and Market Methodology

7 Inflammatory Bowel Disease Epidemiology and Patient Population

8 Inflammatory Bowel Disease Patient Journey

9 Inflammatory Bowel Disease Treatment Algorithm, Inflammatory Bowel Disease Current Treatment, and Medical Practices

10 Key Endpoints in Inflammatory Bowel Disease Clinical Trials

11 Inflammatory Bowel Disease Marketed Therapies 

12 Inflammatory Bowel Disease Emerging Therapies

13 Inflammatory Bowel Disease: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Inflammatory Bowel Disease

16 Inflammatory Bowel Disease Market Key Opinion Leaders Reviews

18 Inflammatory Bowel Disease Market Drivers

19 Inflammatory Bowel Disease Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Inflammatory Bowel Disease Epidemiology 2032

DelveInsight's "Inflammatory Bowel Disease - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Inflammatory Bowel Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

About DelveInsight:

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us:

Kritika Rehani

krehani@delveinsight.com

+91-9650213330

www.delveinsight.com

[ramarochester]

Geriartris - THE Nº1 G.I. MODULATOR                                                                (The New Gen)

(Geriartris is the Worlds Number 1 Microbiome Modulator)

W: www.ramarochester.eu

[drjigarpatel]

Liver Disease Treatment in Gujarat Trusted Specialists

Trusted liver disease treatment in Gujarat with Dr. Jigar Patel. Specialized care for fatty liver, cirrhosis, and digestive disorders. Advanced diagnostic procedures like endoscopy and colonoscopy for effective treatment.

[healthvise]

Inflammatory Bowel Disease: Symptoms, Causes and Treatment

What is inflammatory bowel disease (IBD)? Discover the types, causes, treatments, and symptoms of inflammatory bowel disease (IBD).

[cannabiscomrade]

February 6-10 is Feeding Tube Awareness Week!

The beginning of February was selected because of its proximity to Valentine’s Day, because we love our feeding tubes. This is my first year as a tubie and I’m looking forward to learning more about feeding tubes and the conditions that necessitate them! I do love my tube, it saved my life!

I am an adult with a feeding tube, and a lot of the awareness and attention surrounding these medical devices is child focused. A lot of children depend on tube feeding to thrive, but there are plenty of disabled adults that depend on tube feeding as well! In 2017 there were approximately 438,000 people with feeding tubes in the US, and 60% of them are adults.

I have gastroparesis, which directly translates to paralysis of the stomach. My stomach doesn’t grind food the way it’s supposed to, and my pylorus sphincter at the bottom of my stomach doesn’t open well to pass food and liquids through. While gastroparesis has a range of impact and severity, I have a very severe case, and I am no longer able to eat or drink by mouth for nutrition. I am 100% tube fed. I went into starvation ketoacidosis prior to my placement.

Tube feeding, or enteral nutrition, has several different forms. There are nasal tubes and there are surgical tubes. Nasal tubes can go into your stomach (NG), duodenum (ND), or your jejunum (NJ) and are typically for short-term use. They can be used for acute illness and malnutrition, or to trial tolerance of enteral feeding. Surgical tubes go into your stomach (gastrostomy/G) jejunum (jejunostomy/J) or both (gastrojejunostomy/GJ) and they’re for chronic conditions and/or long-term use. I have a GJ tube and it looks like this:

I have a GJ tube so that I can bypass my paralyzed stomach and feed directly into my intestine. I can also drain stomach contents from the gastric port, which allows me to drink liquids and drain them out before they make me sick. Different people will have different tubes depending on their diagnosis and prognosis! Some people have one form of tube, and others have separate G and J tubes.

There are over 400 conditions that can require tube feeding. Some of those include

Gastroparesis

Intestinal dysmotility

Cancer

Intestinal failure

Inflammatory Bowel Disease (Crohn’s disease and Ulcerative Colitis)

Cerebral Palsy

Congenital/chromosomal conditions

Cyclic Vomiting Syndrome

Ehlers-Danlos Syndrome

Several trisomy conditions

Prematurity

Other conditions not mentioned in the link above include

Hyperemesis gravadarium, severe nausea/vomiting during pregnancy to the point of significant weight loss and electrolyte imbalance

Acute trauma requiring bowel rest

Eating disorders

This week, I want to promote visibility for disabled adults with feeding tubes. I didn’t know anything about enteral nutrition until I got sick. Once I had a confirmed diagnosis of gastroparesis, the reality that I was facing forced me to learn and adapt quickly to a completely life changing treatment. I know there are other adults like me, as well as tubie adults that used to be a child with a tube!